NASDAQ:ATRI - Atrion Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$896.77 +12.62 (+1.43 %)
(As of 05/21/2019 01:36 AM ET)
Previous Close$884.15
Today's Range$882.89 - $896.77
52-Week Range$560.65 - $948.03
Volume2,100 shs
Average Volume6,927 shs
Market Capitalization$1.66 billion
P/E Ratio46.78
Dividend Yield0.61%
Beta0.42
Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications worldwide. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise MPS2 Myocardial Protection System that delivers fluids and medications, mixes critical drugs, and controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measures the activated clotting time of blood; and a line of products designed for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; one-way and two-way pressure relief valves that protect sensitive electronics; and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales personnel, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Receive ATRI News and Ratings via Email

Sign-up to receive the latest news and ratings for ATRI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:ATRI
CUSIP04990410
Phone972-390-9800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$152.45 million
Cash Flow$23.7492 per share
Book Value$117.71 per share

Profitability

Net Income$34.26 million

Miscellaneous

Employees570
Market Cap$1.66 billion
Next Earnings Date8/6/2019 (Estimated)
OptionableNot Optionable

Atrion (NASDAQ:ATRI) Frequently Asked Questions

What is Atrion's stock symbol?

Atrion trades on the NASDAQ under the ticker symbol "ATRI."

How often does Atrion pay dividends? What is the dividend yield for Atrion?

Atrion announced a quarterly dividend on Wednesday, February 27th. Shareholders of record on Friday, March 15th will be paid a dividend of $1.35 per share on Friday, March 29th. This represents a $5.40 dividend on an annualized basis and a yield of 0.60%. The ex-dividend date is Thursday, March 14th. View Atrion's Dividend History.

How were Atrion's earnings last quarter?

Atrion Co. (NASDAQ:ATRI) issued its quarterly earnings results on Tuesday, February, 26th. The medical instruments supplier reported $4.17 earnings per share for the quarter. The medical instruments supplier earned $34.93 million during the quarter. Atrion had a net margin of 22.76% and a return on equity of 16.89%. View Atrion's Earnings History.

When is Atrion's next earnings date?

Atrion is scheduled to release their next quarterly earnings announcement on Tuesday, August 6th 2019. View Earnings Estimates for Atrion.

Has Atrion been receiving favorable news coverage?

News articles about ATRI stock have trended somewhat negative recently, InfoTrie reports. The research firm scores the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Atrion earned a media sentiment score of -1.3 on InfoTrie's scale. They also assigned news articles about the medical instruments supplier a news buzz of 4.0 out of 10, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

Who are some of Atrion's key competitors?

What other stocks do shareholders of Atrion own?

Who are Atrion's key executives?

Atrion's management team includes the folowing people:
  • Mr. Emile A. Battat, Exec. Chairman (Age 81)
  • Mr. David A. Battat, Pres & CEO (Age 49)
  • Mr. Jeffery Strickland, VP, CFO, Treasurer & Sec. (Age 60)

Who are Atrion's major shareholders?

Atrion's stock is owned by a number of of retail and institutional investors. Top institutional investors include Neuberger Berman Group LLC (7.35%), BlackRock Inc. (5.31%), Kayne Anderson Rudnick Investment Management LLC (4.54%), Dimensional Fund Advisors LP (3.45%), Renaissance Technologies LLC (3.20%) and Pennsylvania Trust Co (3.11%). Company insiders that own Atrion stock include Emile A Battat and Jeffery Strickland. View Institutional Ownership Trends for Atrion.

Which major investors are selling Atrion stock?

ATRI stock was sold by a variety of institutional investors in the last quarter, including Kayne Anderson Rudnick Investment Management LLC, Wellington Management Group LLP, Morgan Stanley, THB Asset Management, Renaissance Technologies LLC, Rhumbline Advisers, Royce & Associates LP and KAMES CAPITAL plc. View Insider Buying and Selling for Atrion.

Which major investors are buying Atrion stock?

ATRI stock was purchased by a variety of institutional investors in the last quarter, including Pennsylvania Trust Co, First Trust Advisors LP, Geode Capital Management LLC, SEI Investments Co, Virginia Retirement Systems ET AL, Grisanti Capital Management LLC, Martingale Asset Management L P and JPMorgan Chase & Co.. View Insider Buying and Selling for Atrion.

How do I buy shares of Atrion?

Shares of ATRI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Atrion's stock price today?

One share of ATRI stock can currently be purchased for approximately $896.77.

How big of a company is Atrion?

Atrion has a market capitalization of $1.66 billion and generates $152.45 million in revenue each year. Atrion employs 570 workers across the globe.

What is Atrion's official website?

The official website for Atrion is http://www.atrioncorp.com.

How can I contact Atrion?

Atrion's mailing address is ONE ALLENTOWN PARKWAY, ALLEN TX, 75002. The medical instruments supplier can be reached via phone at 972-390-9800 or via email at [email protected]


MarketBeat Community Rating for Atrion (NASDAQ ATRI)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  92 (Vote Outperform)
Underperform Votes:  91 (Vote Underperform)
Total Votes:  183
MarketBeat's community ratings are surveys of what our community members think about Atrion and other stocks. Vote "Outperform" if you believe ATRI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ATRI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 5/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel